E-LIB Suche - Ergebnisse für: Reda, Moataz - Sprache DE

Sortierung: Relevanz

Sortierung: Jahr

1

Nanotechnology Applications in Breast Cancer Immunotherapy:

Wang, Ruijie ; Kumar, Pramod ; Reda, Moataz...
Small. , 2023

Link: https://doi.org/10.1002/..

2

Development of a nanoparticle-based immunotherapy targeting..:

Reda, Moataz ; Ngamcherdtrakul, Worapol ; Nelson, Molly A....
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

3

Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a T..:

Ngamcherdtrakul, Worapol ; Bejan, Daniel S. ; Cruz‐Muñoz, William...
Small. 18 (2022) 11 - p. , 2022

Link: https://doi.org/10.1002/..

4

Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a T..:

Ngamcherdtrakul, Worapol ; Bejan, Daniel S. ; Cruz‐Muñoz, William...
Small. 18 (2022) 11 - p. , 2022

Link: https://doi.org/10.1002/..

5

Tumor Therapy: In Situ Tumor Vaccination with Nanoparticle ..:

Ngamcherdtrakul, Worapol ; Reda, Moataz ; Nelson, Molly A....
Advanced Materials. 33 (2021) 31 - p. , 2021

Link: https://doi.org/10.1002/..

6

In Situ Tumor Vaccination with Nanoparticle Co‐Delivering C..:

Ngamcherdtrakul, Worapol ; Reda, Moataz ; Nelson, Molly A....
Advanced Materials. 33 (2021) 31 - p. , 2021

Link: https://doi.org/10.1002/..

7

Augmenting the therapeutic window of radiotherapy: A perspe..:

Reda, Moataz ; Bagley, Alexander F. ; Zaidan, Husam Y..
Radiotherapy and Oncology. 150 (2020) - p. 225-235 , 2020

Link: https://doi.org/10.1016/..

8

PLK1 and EGFR targeted nanoparticle as a radiation sensitiz..:

Reda, Moataz ; Ngamcherdtrakul, Worapol ; Gu, Shenda...
Cancer Letters. 467 (2019) - p. 9-18 , 2019

Link: https://doi.org/10.1016/..

9

Lanthanide-Loaded Nanoparticles as Potential Fluorescent an..:

Ngamcherdtrakul, Worapol ; Sangvanich, Thanapon ; Goodyear, Shaun...
Bioengineering. 6 (2019) 1 - p. 23 , 2019

Link: https://doi.org/10.3390/..

10

Removal of a gadolinium based contrast agent by a novel sor..:

Ngamcherdtrakul, Worapol ; Morry, Jingga ; Sangvanich, Thanapon...
Scientific Reports. 9 (2019) 1 - p. , 2019

Link: https://doi.org/10.1038/..

11

Lack of acquired resistance in HER2-positive breast cancer ..:

Gu, Shenda ; Ngamcherdtrakul, Worapol ; Reda, Moataz...
PLOS ONE. 13 (2018) 6 - p. e0198141 , 2018

Link: https://doi.org/10.1371/..

12

Lyophilization and stability of antibody-conjugated mesopor..:

Ngamcherdtrakul, Worapol ; Sangvanich, Thanapon ; Reda, Moataz...
International Journal of Nanomedicine. 13 (2018) - p. 4015-4027 , 2018

Link: https://doi.org/10.2147/..

13

Current development of targeted oligonucleotide-based cance..:

Ngamcherdtrakul, Worapol ; Castro, David J. ; Gu, Shenda...
Cancer Treatment Reviews. 45 (2016) - p. 19-29 , 2016

Link: https://doi.org/10.1016/..

14

Erratum to "Dermal delivery of HSP47 siRNA with NOX4-modula..:

Morry, Jingga ; Ngamcherdtrakul, Worapol ; Gu, Shenda...
Biomaterials. 74 (2016) - p. 292 , 2016

Link: https://doi.org/10.1016/..

15

Therapeutic siRNA for drug-resistant HER2-positive breast c..:

Gu, Shenda ; Hu, Zhi ; Ngamcherdtrakul, Worapol...
Oncotarget. 7 (2016) 12 - p. 14727-14741 , 2016

Link: https://doi.org/10.18632..

1-15